SCHEMBL30184486

SCHEMBL30184486

C#CCNc1ccc([PH2]=O)c2scnc12

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 6/20 0.32
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29212385 0.78 GRM1 (0.32) GRM1KCNH2
SCHEMBL31270466 0.77 GRM1 (0.31) GRM1KCNH2
SCHEMBL30184629 0.77 GRM1 (0.33) GRM1KCNH2
SCHEMBL5509091 0.56 PDPK1 (0.35) —
SCHEMBL15096378 0.55 MEN1 (0.62) —
SCHEMBL23853599 0.54 HDAC1 (0.58) —
SCHEMBL29777953 0.53 MAOA (0.57) —
SCHEMBL26395917 0.53 CYP1A2 (0.38) —
SCHEMBL20999929 0.53 ALDH1A1 (0.43) —
SCHEMBL10922315 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384510-A1 COMPOUNDS TARGETING MUTANT OF P53 Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-06-19 — — EP disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed
Send feedback